Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects
Clinical trial NCT02364635 · COMPLETED
Trial details
- NCT number
- NCT02364635
- Sponsor
- Pronova BioPharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.